- Research news
- Published:
A protein kinase switch
Genome Biology volume 1, Article number: spotlight-20000929-01 (2000)
Kinase inhibitors are plagued by a lack of specificity. Now in the 21 September Nature Bishop et al. tackle the problem by building on their earlier work, in which they modified the ATP-binding sites of Src-family tyrosine kinases to accept either nucleotide analogs or modified kinase inhibitors. In the new work the researchers mutate kinases from four distinct kinase families by replacing a bulky residue with a small residue. This change provides enough room for the binding of inhibitor analogs, which are larger than their parent inhibitors and thus do not inhibit wild-type kinases (Nature 2000, 407:395-401). The in vivo specificity is demonstrated using expression arrays. Most kinases contain a bulky residue analogous to the one mutated in this study, and thus should be amenable to the kinase-sensitization strategy.
References
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
Nature, [http://www.nature.com/nature/]
Engineering Src family protein kinases with unnatural nucleotide specificity.
Rights and permissions
About this article
Cite this article
Wells, W. A protein kinase switch. Genome Biol 1, spotlight-20000929-01 (2000). https://doi.org/10.1186/gb-spotlight-20000929-01
Published:
DOI: https://doi.org/10.1186/gb-spotlight-20000929-01
Keywords
- Nucleotide
- Tyrosine
- Protein Kinase
- Tyrosine Kinase
- Kinase Inhibitor